ASSOCIATION OF THROMBOCYTOPENIA, ACTIVATED PARTIAL THROMBOPLASTIN TIME WITH BLEEDING MANIFESTATION IN DENGUE PATIENTS
Main Article Content
Keywords
Dengue, Thrombocytopenia, Aptt, Bleeding manifestation, RDP transfusion.
Abstract
Dengue virus infection can lead to severe complications, including bleeding, due to alterations in coagulation pathways. One of the key laboratory tests used to assess coagulation status is the activated partial thromboplastin time (aPTT), which measures the time it takes for blood to clot. In dengue, coagulopathy, including thrombocytopenia and endothelial dysfunction, can result in prolonged aPTT, serving as a potential early indicator of bleeding risk. A prolonged aPTT, especially when combined with low platelet counts and other clinical signs of hemorrhage, can predict the onset of severe conditions such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Monitoring aPTT levels in dengue patients allows for the early identification of coagulopathy, enabling clinicians to take proactive measures, such as platelet transfusion and more intensive management, to prevent life-threatening bleeding episodes. This abstract highlights the significance of aPTT as an early predictor of bleeding in dengue virus infection, underscoring its role in guiding clinical decisions and improving patient outcomes in severe cases.
References
2. Dung, N. M., et al. (2000). Coagulation disorders and bleeding complications in dengue virus infection: a prospective study. Thrombosis and Haemostasis, 83(6), 889-894.
3. Hornsby, J. M., et al. (2015). Dengue virus infection and its impact on coagulation. Journal of Clinical Microbiology, 53(9), 2870-2875.
4. Kalayanarooj, S. (2011). Dengue: clinical manifestations and management. Viral Immunology, 24(3), 231-237.
5. Wills, B. A., et al. (2009). Dengue and severe dengue: epidemiology and clinical management. Lancet Infectious Diseases, 9(11), 13-20.
6. Srichaikul T, Nimmannitya S. Hemostatic defects in dengue hemorrhagic fever. Thromb Haemost. 2000;84(1):1-7.
7. Khan SA, Syed MA, Qureshi AR. Platelet count and bleeding manifestations in dengue fever. J Pak Med Assoc. 2017;67(4):538-42.
8. Makroo RN, Raina V, Kumar P. Coagulation abnormalities in dengue hemorrhagic fever. Asian J Transfus Sci. 2018;12(2):112-7.
9. Hottz ED, Oliveira MF, Nunes PC. Platelet activation and apoptosis in dengue: implications for thrombocytopenia and hemostasis. PLoS Pathog. 2013;9(3):e1003056.
10. Krishnamurti C, Kalayanarooj S, Cutting MA. Mechanisms of hemorrhage in dengue without circulatory collapse. Am J Trop Med Hyg. 2001;65(6):840-7.
11. World Health Organization (WHO). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva: WHO; 2009.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Suman G R
Professor, Department of General Medicine, S.S Institute of Medical Sciences, Davangere, Karnataka,
Dr Hoysala Kumar D P
Assistant Professor, Department of General Medicine, S.S Institute of Medical Sciences, Davangere, Karnataka
Dr Bharath S J
Junior Resident, Department of General Medicine, S.S Institute of Medical Sciences, Davangere, Karnataka,